Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice

Circ Res. 1999 Aug 6;85(3):288-93. doi: 10.1161/01.res.85.3.288.

Abstract

Nitric oxide and prostaglandins were shown to contribute to the endothelial mediation of flow-induced dilation of skeletal muscle arterioles of rats. Thus, we hypothesized that flow-induced dilation and its mediation are altered in gracilis muscle arterioles of mice deficient in the gene for endothelial nitric oxide synthase (eNOS-KO) compared with control wild-type (WT) mice. Gracilis muscle arterioles ( approximately 80 micrometer) of male mice were isolated, then cannulated and pressurized in a vessel chamber. The increases in diameter elicited by increases in perfusate flow from 0 to 10 microq/min were similar in arterioles from eNOS-KO (n=28) and WT (n=22) mice ( approximately 20 micrometer at 10 microL/min flow). Removal of the endothelium eliminated flow-induced dilations in vessels of both strains of mice. N(omega)-nitro-L-arginine (L-NNA, 10(-4) mol/L) significantly inhibited flow-induced dilation in arterioles of WT mice by approximately 51% but had no effect on responses of arterioles from eNOS-KO mice. Indomethacin (INDO, 10(-5) mol/L) inhibited flow-induced dilation of WT mice by approximately 49%, whereas it completely abolished this response in arterioles of eNOS-KO mice. Simultaneous administration of INDO and L-NNA eliminated flow-induced responses in arterioles of WT mice. Dilations to carbaprostacyclin were similar at concentrations of 10(-8) and 3x10(-8) mol/L but decreased significantly at 10(-7) mol/L in arterioles of eNOS-KO compared with those of WT mice. These findings demonstrate that, despite the lack of nitric oxide mediation, flow-induced dilation is close to normal in arterioles of eNOS-KO mice because of an enhanced release of endothelial dilator prostaglandins and suggest that this vascular adaptation may contribute to the regulation of peripheral resistance in eNOS-KO mice.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arterioles / physiology*
  • Blood Circulation / physiology*
  • Cyclooxygenase Inhibitors / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Epoprostenol / analogs & derivatives
  • Epoprostenol / pharmacology
  • In Vitro Techniques
  • Indomethacin / pharmacology
  • Male
  • Mice
  • Mice, Knockout / genetics
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / deficiency*
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nitroarginine / pharmacology
  • Prostaglandins / metabolism*
  • Vasodilation / drug effects
  • Vasodilation / physiology*

Substances

  • Cyclooxygenase Inhibitors
  • Enzyme Inhibitors
  • Prostaglandins
  • Nitroarginine
  • carboprostacyclin
  • Epoprostenol
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse
  • Indomethacin